Liver, Digestive, and Metabolic Disorders Laboratory, Carolinas Medical Center, Charlotte, North Carolina 28203, USA.
J Biol Chem. 2011 Jul 29;286(30):26424-30. doi: 10.1074/jbc.M110.215772. Epub 2011 Jun 9.
5-Aminolevulinic acid synthase (ALAS-1) is the first rate controlling enzyme that controls cellular heme biosynthesis. Negative feedback regulation of ALAS-1 by the end product heme is well documented and provides the foundation for heme treatment of acute porphyrias, a group of diseases caused by genetic defects in the heme biosynthesis pathway and exacerbated by controlled up-regulation of ALAS-1. Heme is known to affect ALAS-1 activity by repressing gene transcription, accelerating mRNA degradation, and impeding pre-ALAS-1 mitochondrial translocation. In the current study, we examined the effect of heme on the rate of mature ALAS-1 protein turnover in human cells and tissues and explored the mediator involved in this new regulatory mechanism. We found that heme and other metalloporphyrins such as CoPP and CrPP decreased mitochondrial ALAS-1 protein through proteolysis. This degradative effect cannot be emulated by iron or free protoporphyrin, two major chemical components of the heme ring, and is independent of oxidative stress. Down-regulating the activity of mitochondrial LONP1, an ATP-dependent protease that controls the selective turnover of mitochondrial matrix proteins, with potent inhibitors and specific siRNA diminished the negative effect of heme on mitochondrial ALAS-1. Therefore, our data support the existence of a conserved heme feedback regulatory mechanism that functions on the mature form of ALAS-1 protein through the activity of a mitochondrial proteolytic system.
5-氨基酮戊酸合酶(ALAS-1)是控制细胞血红素生物合成的第一个限速酶。血红素对 ALAS-1 的负反馈调节已有充分的文献记载,为血红素治疗急性卟啉症提供了基础,急性卟啉症是一组由血红素生物合成途径中的遗传缺陷引起的疾病,受 ALAS-1 的控制上调而加重。血红素通过抑制基因转录、加速 mRNA 降解和阻碍前 ALAS-1 线粒体易位来影响 ALAS-1 活性。在本研究中,我们检查了血红素对人细胞和组织中成熟 ALAS-1 蛋白周转率的影响,并探讨了参与这种新的调节机制的中介物。我们发现血红素和其他金属卟啉,如 CoPP 和 CrPP,通过蛋白水解作用降低线粒体 ALAS-1 蛋白。这种降解作用不能被血红素环的两个主要化学组成部分铁或游离原卟啉模拟,并且与氧化应激无关。用有效的抑制剂和特定的 siRNA 下调控制线粒体基质蛋白选择性周转的线粒体 LONP1(一种 ATP 依赖性蛋白酶)的活性,可减轻血红素对线粒体 ALAS-1 的负向作用。因此,我们的数据支持存在一种保守的血红素反馈调节机制,该机制通过线粒体蛋白水解系统的活性作用于 ALAS-1 蛋白的成熟形式。